Capsaicin

Speaker 1…so, we’re looking at capsaicin, often used for pain relief, acting on TRPV1 channels to essentially desensitize nerve endings. It’s effective for many, but the real question is how its long-term use intersects with biological aging and all-cause mortality.

Speaker 2Exactly. The evidence is complex. On one hand, untreated chronic pain itself can accelerate biological aging. For example, a study in *GeroScience* in 2025 (PMID 39847262) found that painful diabetic neuropathy is linked to accelerated epigenetic aging and telomere shortening compared to painless neuropathy. So, pain relief is crucial.

Speaker 1That’s a critical point. Alleviating pain can improve quality of life and potentially mitigate some aspects of accelerated aging due to chronic inflammation. However, directly linking capsaicin use to slowing or accelerating biological aging or impacting all-cause mortality is where the evidence gets much less clear.

Speaker 2Right. We have solid data showing capsaicin’s mechanism for pain relief. What we *don't* have is robust, long-term human trial data specifically demonstrating that capsaicin *itself* either improves or worsens biological aging markers, like the epigenetic clock, or significantly alters all-cause mortality.

Speaker 1So, while relieving pain is beneficial, we can’t extrapolate that directly to capsaicin being a "longevity drug." Its primary role is managing pain, which indirectly helps by addressing a known accelerator of aging.

Speaker 2And there are no established long-term harms like dependence, sedation, or significant cognitive or cardiovascular/GI risks directly attributable to topical capsaicin, unlike some other pain medications. The balance is ensuring pain is managed appropriately, weighing known benefits against what remains unproven regarding aging pathways.